BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18307872)

  • 1. [Trends in pathology research of liver tumors].
    Zhu MH
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):721-2. PubMed ID: 18307872
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers.
    Lee CH; Hsieh SY; Chang CJ; Lin YJ
    J Gastroenterol Hepatol; 2013 Jan; 28(1):122-7. PubMed ID: 23034166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.
    Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX
    J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
    Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
    Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
    Watanabe M; Akagi S; Hamamoto S
    Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B virus and intrahepatic cholangiocarcinoma.
    Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
    Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver cancer, the prevention and control in Thailand.
    Phornphutkul K
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():209-13. PubMed ID: 11890107
    [No Abstract]   [Full Text] [Related]  

  • 11. Biliary tumors of the liver.
    Colombari R; Tsui WM
    Semin Liver Dis; 1995 Nov; 15(4):402-13. PubMed ID: 8578323
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of small combined hepatocellular and cholangiocellular carcinoma arising in a nodule of atypical adenomatous hyperplasia of the liver.
    Harada K; Terada T; Nakanuma Y; Furukawa Y; Kurumaya H
    Am J Gastroenterol; 1993 Nov; 88(11):1968-9. PubMed ID: 8237956
    [No Abstract]   [Full Text] [Related]  

  • 13. [Case 6: Combined hepatocellular and cholangiocarcinoma].
    Bedossa P
    Ann Pathol; 2007 Apr; 27(2):112-4. PubMed ID: 17909467
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of hepatocellular-cholangiocarcinoma invading the gallbladder].
    Namkoong KY; Kang MJ; Im HM; Kim MS; Ko BS; Ahn HT; Lee JR; Kim JO
    Korean J Hepatol; 2004 Jun; 10(2):148-53. PubMed ID: 15218349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [E-cadherin].
    Kato M; Terada T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():195-200. PubMed ID: 11761940
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathology of combined hepatocellular-cholangiocarcinoma.
    Yeh MM
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1485-92. PubMed ID: 20796144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma.
    Lee JH; Chung GE; Yu SJ; Hwang SY; Kim JS; Kim HY; Yoon JH; Lee HS; Yi NJ; Suh KS; Lee KU; Jang JJ; Kim YJ
    J Clin Gastroenterol; 2011 Jan; 45(1):69-75. PubMed ID: 20142755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
    Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
    Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients.
    Nagafuchi Y; Okamoto K; Shono M; Higure A; Todoroki H; Itoh H; Takeda S; Katumoto F; Toyoshima S
    Hepatogastroenterology; 1998; 45(20):523-7. PubMed ID: 9638442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.